Sadek v. Wesley

117 A.D.3d 193, 986 N.Y.S.2d 25

This text of 117 A.D.3d 193 (Sadek v. Wesley) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sadek v. Wesley, 117 A.D.3d 193, 986 N.Y.S.2d 25 (N.Y. Ct. App. 2014).

Opinions

OPINION OF THE COURT

Saxe, J.

The question raised by this appeal is whether the trial court properly granted defendants’ in limine motions and precluded plaintiffs neurological experts from testifying, on the grounds that the first expert’s theory of causation was negated by a supplemental report and that the second expert’s theories of causation either failed to pass the Frye test or were untimely [196]*196raised. We hold that the proposed testimony by plaintiff’s experts should not have been precluded. The essence of these witnesses’ position on causation—the unremarkable premise that the physical trauma caused by the motor vehicle collision was a competent producing cause of plaintiffs embolic stroke— did not require a formal Frye hearing. Moreover, even if a Frye hearing was appropriate, the evidence before the court was sufficient under Frye to avoid preclusion of the testimony.

This action arose out of a motor vehicle accident that occurred on October 2, 2006 between a limousine driven by plaintiff Kamal Sadek and a Greyhound bus operated by defendant Aaron Jenkins (sued herein as Jenkins A. Wesley). Plaintiff asserts that during the accident his head slammed against his side window. After both drivers exited their vehicles and began an angry verbal exchange, plaintiff became faint and dizzy, started to shake, and found that he needed to sit down. He then became unresponsive, and was transported to St. Luke’s Roosevelt Hospital, where he was diagnosed with an embolic stroke, also called a cerebral vascular accident (CVA). A report from St. Luke’s Roosevelt Hospital dated October 4, 2006 described the results of two tests performed on plaintiff: a transesophageal echocardiogram disclosed a mobile thrombus (a large blood clot) anchored to the left subclavian artery, and a magnetic resonance angiogram reportedly disclosed atheroma (plaque) in the aortic arch. Plaintiff was placed on aspirin and Plavix.

Plaintiff brought this action against the bus company and the bus driver, alleging that the accident was caused by the negligence of the driver, and that it precipitated the embolic stroke, or “aggravated, activated and/or precipitated any underlying . . . circulatory, arterial, venous or systemic condition, which was asymptomatic prior to the accident.”

Plaintiff designated Dr. Nabil Yazgi as his neurological expert. His CPLR 3101 (d) notice stated that Dr. Yazgi, a neurologist who served as director of the Stroke Center at New York Presbyterian Hospital, would testify at trial in conformity with his report dated September 23, 2010. In that report, Dr. Yazgi stated that there was a “probable causal relationship” between the motor vehicle accident and the CVA.

However, in a supplemental report dated June 28, 2011, Dr. Yazgi pointed out that a medical report dated November 28, 2006, some eight weeks after the original October 4, 2006 report, stated that the thrombus and atheroma observed in the October [197]*1974, 2006 report were no longer evident. Dr. Yazgi stated that “[t]his is physiologically unlikely[,] which suggests the first report was possibly artifact,”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Parker v. Mobil Oil Corp.
857 N.E.2d 1114 (New York Court of Appeals, 2006)
Nonnon v. City of New York
874 N.E.2d 720 (New York Court of Appeals, 2007)
Price v. New York City Housing Authority
706 N.E.2d 1167 (New York Court of Appeals, 1998)
Bardons & Oliver, Inc. v. Amtorg Trading Corp.
274 A.D. 982 (Appellate Division of the Supreme Court of New York, 1948)
Bernstein v. City of New York
511 N.E.2d 52 (New York Court of Appeals, 1987)
Lissak v. Cerabona
10 A.D.3d 308 (Appellate Division of the Supreme Court of New York, 2004)
Marsh v. Smyth
12 A.D.3d 307 (Appellate Division of the Supreme Court of New York, 2004)
Zito v. Zabarsky
28 A.D.3d 42 (Appellate Division of the Supreme Court of New York, 2006)
Nonnon v. City of New York
32 A.D.3d 91 (Appellate Division of the Supreme Court of New York, 2006)
Mead v. Dr. Rajadhyax' Dental Group
34 A.D.3d 1139 (Appellate Division of the Supreme Court of New York, 2006)
Guzman v. 4030 Bronx Boulevard Associates L.L.C.
54 A.D.3d 42 (Appellate Division of the Supreme Court of New York, 2008)
LaFurge v. Cohen
61 A.D.3d 426 (Appellate Division of the Supreme Court of New York, 2009)
Capital Master Fund LP v. Wachovia Capital Markets, LLC
95 A.D.3d 620 (Appellate Division of the Supreme Court of New York, 2012)
Stanski v. Ezersky
228 A.D.2d 311 (Appellate Division of the Supreme Court of New York, 1996)
Downtown Art Co. v. Zimmerman
232 A.D.2d 270 (Appellate Division of the Supreme Court of New York, 1996)
Carter v. Metro North Associates
255 A.D.2d 251 (Appellate Division of the Supreme Court of New York, 1998)
Ruskin v. Safir
258 A.D.2d 268 (Appellate Division of the Supreme Court of New York, 1999)
Barksdale v. New York City Transit Authority
294 A.D.2d 210 (Appellate Division of the Supreme Court of New York, 2002)
Lara v. New York City Health & Hospitals Corp.
305 A.D.2d 106 (Appellate Division of the Supreme Court of New York, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
117 A.D.3d 193, 986 N.Y.S.2d 25, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sadek-v-wesley-nyappdiv-2014.